1. Home
  2. DRUG
  3. DRUG News

Latest Bright Minds Biosciences Inc. (DRUG) News on May 10, 2025

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study
DRUG

GlobeNewswire

12 days ago

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research
DRUG

GlobeNewswire

2 months ago

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
DRUG

GlobeNewswire

3 months ago

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
DRUG

GlobeNewswire

4 months ago

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
DRUG

GlobeNewswire

6 months ago

Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting

Bright Minds Biosciences Secures $35 Million Investment
DRUG

TipRanks

6 months ago

Bright Minds Biosciences Secures $35 Million Investment

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
DRUG

GlobeNewswire

6 months ago

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
DRUG

GlobeNewswire

7 months ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement
DRUG

GlobeNewswire

7 months ago

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models
DRUG

GlobeNewswire

7 months ago

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology
DRUG

GlobeNewswire

7 months ago

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Biotech stock tumbles after unexplained 1,446% gain
DRUG

MarketWatch

7 months ago

Biotech stock tumbles after unexplained 1,446% gain

Bright Minds is Unaware of Any Material Changes
DRUG

Newsfile

7 months ago

Bright Minds is Unaware of Any Material Changes

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events
DRUG

GlobeNewswire

7 months ago

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
DRUG

GlobeNewswire

8 months ago

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy
DRUG

CNW Group

8 months ago

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Start Proud Opens the Market
DRUG

CNW Group

a year ago

Start Proud Opens the Market

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it
DRUG

Associated Press Finance

a year ago

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

DRUG

Business Wire

a year ago

Form 8.3 - Darktrace plc

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives
DRUG

Investor's Business Daily

a year ago

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

May jobs reports signals Fed's soft landing: US Labor Secretary
DRUG

Yahoo Finance Video

a year ago

May jobs reports signals Fed's soft landing: US Labor Secretary

Notification of major holding in Kindred Group plc
DRUG

PR Newswire

a year ago

Notification of major holding in Kindred Group plc

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024
DRUG

Business Wire

a year ago

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

DRUG

Business Wire

a year ago

Form 8.3 - DS Smith plc

Summit State Bank (NASDAQ:SSBI) Will Pay A Dividend Of $0.12
DRUG

Simply Wall St.

a year ago

Summit State Bank (NASDAQ:SSBI) Will Pay A Dividend Of $0.12

When 2 Million Is Not Enough: ECD Auto Design Unveils Cutting-Edge Web Configurator for Custom Vehicles
DRUG

PR Newswire

a year ago

When 2 Million Is Not Enough: ECD Auto Design Unveils Cutting-Edge Web Configurator for Custom Vehicles

AmpliTech Group’s Division, AmpliTech Inc, Unveils Its New KA LNB Unit, Designed For Superior Performance In LEO, MEO, GEO And KA Band Teleport Applications
DRUG

GlobeNewswire

a year ago

AmpliTech Group’s Division, AmpliTech Inc, Unveils Its New KA LNB Unit, Designed For Superior Performance In LEO, MEO, GEO And KA Band Teleport Applications

DRUG

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/25/2024

Sports Illustrated Announces Major Layoffs, Putting the Brand’s Future in Jeopardy
DRUG

The Wall Street Journal

a year ago

Sports Illustrated Announces Major Layoffs, Putting the Brand’s Future in Jeopardy

The Arena Group Announces Workforce Reductions in Strategic Move to Transform the Business Model
DRUG

Business Wire

a year ago

The Arena Group Announces Workforce Reductions in Strategic Move to Transform the Business Model

Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why
DRUG

Zacks

a year ago

Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why

MariaDB Reaches Agreement to Amend Senior Secured Promissory Note
DRUG

Business Wire

a year ago

MariaDB Reaches Agreement to Amend Senior Secured Promissory Note

Ohmyhome and Webuy Announce Strategic Collaboration to Cross-Sell Products and Services Across Singapore
DRUG

GlobeNewswire

a year ago

Ohmyhome and Webuy Announce Strategic Collaboration to Cross-Sell Products and Services Across Singapore

Electra Appoints 30-year Finance Veteran as CFO and Provides Financing Update
DRUG

Business Wire

a year ago

Electra Appoints 30-year Finance Veteran as CFO and Provides Financing Update

4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow
DRUG

Zacks

a year ago

4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow

KULR Announces Proposed Public Offering of Common Stock
DRUG

GlobeNewswire

a year ago

KULR Announces Proposed Public Offering of Common Stock

DRUG

PR Newswire

a year ago

SCULLY ROYALTY LTD. PUBLISHES RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023

The Arena Group Announces Termination Of CEO Ross Levinsohn, Appoints Manoj Bhargava As Interim CEO
DRUG

Business Wire

a year ago

The Arena Group Announces Termination Of CEO Ross Levinsohn, Appoints Manoj Bhargava As Interim CEO

EpicQuest Education Announces Launch of New Business Segment to Focus on Kinesiology and Recreation Education
DRUG

PR Newswire

a year ago

EpicQuest Education Announces Launch of New Business Segment to Focus on Kinesiology and Recreation Education

DRUG

CNW Group

a year ago

Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management

BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity
DRUG

GlobeNewswire

a year ago

BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity

Deion "Coach Prime" Sanders Named 2023 Sports Illustrated Sportsperson of the Year
DRUG

Business Wire

a year ago

Deion "Coach Prime" Sanders Named 2023 Sports Illustrated Sportsperson of the Year

Bruker's (BRKR) New Collaboration to Use MALDI Biotyper System
DRUG

Zacks

a year ago

Bruker's (BRKR) New Collaboration to Use MALDI Biotyper System

Splash Beverage Groups Copa di Vino Brand Received Walmart’s Coveted Golden Ticket Award for Its Lineup of Premium Single Serve Wine
DRUG

GlobeNewswire

a year ago

Splash Beverage Groups Copa di Vino Brand Received Walmart’s Coveted Golden Ticket Award for Its Lineup of Premium Single Serve Wine

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Call Transcript
DRUG

Insider Monkey

a year ago

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Call Transcript

DRUG

Associated Press Finance

a year ago

Sonim: Q3 Earnings Snapshot

DRUG

Business Wire

a year ago

The Arena Group Reports Third Quarter 2023 Financial Results; Advances Bridge Media Acquisition

Snail, Inc. Reports Third Quarter 2023 Financial Results
DRUG

GlobeNewswire

a year ago

Snail, Inc. Reports Third Quarter 2023 Financial Results

Sonim Reports 34% Revenue Increase to $27.6 Million, Continued GAAP Profitability in Third Quarter 2023
DRUG

Newsfile

a year ago

Sonim Reports 34% Revenue Increase to $27.6 Million, Continued GAAP Profitability in Third Quarter 2023

Epsilon Energy Ltd. (NASDAQ:EPSN) Q3 2023 Earnings Call Transcript
DRUG

Insider Monkey

a year ago

Epsilon Energy Ltd. (NASDAQ:EPSN) Q3 2023 Earnings Call Transcript

DRUG

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Fossil Group Inc Earnings Call

DRUG

Associated Press Finance

2 years ago

Fossil Group: Q3 Earnings Snapshot

Fossil Group, Inc. Reports Third Quarter 2023 Financial Results
DRUG

GlobeNewswire

2 years ago

Fossil Group, Inc. Reports Third Quarter 2023 Financial Results

Logan Ridge Finance Corporation Announces Third Quarter 2023 Financial Results
DRUG

GlobeNewswire

2 years ago

Logan Ridge Finance Corporation Announces Third Quarter 2023 Financial Results

Nortech Systems Reports Third Quarter 2023 Results
DRUG

Business Wire

2 years ago

Nortech Systems Reports Third Quarter 2023 Results

Orion Energy Systems, Inc. (NASDAQ:OESX) Q2 2024 Earnings Call Transcript
DRUG

Insider Monkey

2 years ago

Orion Energy Systems, Inc. (NASDAQ:OESX) Q2 2024 Earnings Call Transcript

DRUG

Business Wire

2 years ago

The Arena Group to Host Third Quarter 2023 Financial Results Conference Call on Tuesday, November 14

Inspirato Announces Third Quarter Results
DRUG

GlobeNewswire

2 years ago

Inspirato Announces Third Quarter Results

DRUG

Business Wire

2 years ago

The Arena Group Signs Definitive Agreement to Combine with Bridge Media Networks

Indaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune Response of More than Fifty Cytokines and Chemokines in Patients Following a Single Dose in First Cohort of Ongoing Phase 1 Study
DRUG

GlobeNewswire

2 years ago

Indaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune Response of More than Fifty Cytokines and Chemokines in Patients Following a Single Dose in First Cohort of Ongoing Phase 1 Study

HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
DRUG

GlobeNewswire

2 years ago

HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023

The Arena Group Names Katie Kulik as Chief Revenue Officer to Drive Growth and Innovation
DRUG

Business Wire

2 years ago

The Arena Group Names Katie Kulik as Chief Revenue Officer to Drive Growth and Innovation

Eargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and Innovation
DRUG

GlobeNewswire

2 years ago

Eargo Celebrates 1-Year Anniversary of FDA's Over-the-Counter (OTC) Hearing Aid Regulations, Driving a New Era of Accessibility and Innovation

Share on Social Networks: